StockData
BioAtla, Inc. logo

BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for BioAtla

BioAtla has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BioAtla figures

See a number that looks wrong?